Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – MENAFN.COM
|
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …
MENAFN.COM SUNRISE, FL, Sep 23, 2013 (Menafn – Marketwired via COMTEX) –Bioheart, Inc. (otcqb:BHRT), a biotech company focused on thediscovery, development and commercialization of autologous celltherapies for the treatment of chronic and acute heart damage … |
